Covid-19: From structure to therapeutic targeting in studying approved drugs and local DNA vaccination.
作者信息
Wang Zhiguo, Hong Xiaojing, Wang Hongyan, Liu Jun, Liu Jun-Ping
机构信息
Institute of Ageing Research, Hangzhou Normal University, School of Medicine, Hangzhou, China.
Department of Immunology, Central Clinical School, Faculty of Medicine, Monash University, Prahran, Vic., Australia.
出版信息
Clin Exp Pharmacol Physiol. 2020 Nov;47(11):1771-1773. doi: 10.1111/1440-1681.13409.
Abstract
摘要
相似文献
1
Covid-19: From structure to therapeutic targeting in studying approved drugs and local DNA vaccination.
Clin Exp Pharmacol Physiol. 2020 Nov;47(11):1771-1773. doi: 10.1111/1440-1681.13409.
2
COVID-19: Some clinical questions after the first 4 months.
Eur J Clin Invest. 2020 Jul;50(7):e13326. doi: 10.1111/eci.13326. Epub 2020 Jul 5.
3
COVID-19: The Need for Immunoprevention at Industrial Scale.
Am J Trop Med Hyg. 2020 Jun;102(6):1151. doi: 10.4269/ajtmh.20-0239.
4
Combination prevention for COVID-19.
Science. 2020 May 8;368(6491):551. doi: 10.1126/science.abc5798.
5
NIH organizes hunt for drugs.
Science. 2020 Apr 24;368(6489):351. doi: 10.1126/science.368.6489.351.
6
Experts Discuss COVID-19-Remdesivir, Vaccines, and More.
JAMA. 2020 Aug 25;324(8):730-731. doi: 10.1001/jama.2020.15067.
7
SARS-CoV-2: a time for clear and immediate action.
Lancet Infect Dis. 2020 May;20(5):531-532. doi: 10.1016/S1473-3099(20)30250-4. Epub 2020 Mar 31.
8
Emerging prophylaxis strategies against COVID-19.
Monaldi Arch Chest Dis. 2020 Mar 30;90(1). doi: 10.4081/monaldi.2020.1289.
9
The Equitable Distribution of COVID-19 Therapeutics and Vaccines.
JAMA. 2020 Jun 23;323(24):2462-2463. doi: 10.1001/jama.2020.6641.
10
COVID-19 pandemic: what can pharmaceutical formulation and drug delivery experts offer?
Pharm Dev Technol. 2020 Jul;25(6):649. doi: 10.1080/10837450.2020.1764670.
本文引用的文献
1
Shining Light on the COVID-19 Pandemic: A Vitamin D Receptor Checkpoint in Defense of Unregulated Wound Healing.
Cell Metab. 2020 Nov 3;32(5):704-709. doi: 10.1016/j.cmet.2020.09.007. Epub 2020 Sep 11.
2
Comparison of Clinical Features of COVID-19 vs Seasonal Influenza A and B in US Children.
JAMA Netw Open. 2020 Sep 1;3(9):e2020495. doi: 10.1001/jamanetworkopen.2020.20495.
3
Hypothesis: The potential therapeutic role of nicorandil in COVID-19.
Clin Exp Pharmacol Physiol. 2020 Nov;47(11):1791-1797. doi: 10.1111/1440-1681.13395. Epub 2020 Sep 9.
4
A novel concept for treatment and vaccination against Covid-19 with an inhaled chitosan-coated DNA vaccine encoding a secreted spike protein portion.
Clin Exp Pharmacol Physiol. 2020 Nov;47(11):1874-1878. doi: 10.1111/1440-1681.13393. Epub 2020 Sep 10.
5
MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses.
Science. 2020 Oct 9;370(6513):241-247. doi: 10.1126/science.abb3753. Epub 2020 Aug 27.
6
The effect of quercetin on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: A rapid review.
Adv Integr Med. 2020 Dec;7(4):247-251. doi: 10.1016/j.aimed.2020.07.007. Epub 2020 Jul 30.
7
Teaching Old Drugs New Tricks: Statins for COVID-19?
Cell Metab. 2020 Aug 4;32(2):145-147. doi: 10.1016/j.cmet.2020.07.006.
8
Is a "Cytokine Storm" Relevant to COVID-19?
JAMA Intern Med. 2020 Sep 1;180(9):1152-1154. doi: 10.1001/jamainternmed.2020.3313.
9
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19.
Cell Metab. 2020 Aug 4;32(2):176-187.e4. doi: 10.1016/j.cmet.2020.06.015. Epub 2020 Jun 24.
10
Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells.
Biomedicines. 2020 May 21;8(5):129. doi: 10.3390/biomedicines8050129.
Zotero 插件